ROIV

Roivant Sciences Ltd.

9.39 USD
+0.30 (+3.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Roivant Sciences Ltd. stock is up 8.68% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
07 Nov 20:06 19 Jan, 2024 10.00 PUT 209 338
09 Nov 15:02 15 Dec, 2023 10.00 CALL 900 2547
09 Nov 16:44 17 Jan, 2025 12.50 CALL 451 2
09 Nov 20:55 17 May, 2024 10.00 CALL 500 187
10 Nov 16:46 17 May, 2024 10.00 CALL 283 687
14 Nov 15:01 19 Jan, 2024 10.00 CALL 500 110
15 Nov 17:43 15 Dec, 2023 10.00 CALL 1000 3462
20 Nov 20:37 15 Dec, 2023 10.00 CALL 2500 3451
22 Nov 18:07 16 Feb, 2024 15.00 CALL 3900 9215
28 Nov 17:28 16 Jan, 2026 10.00 PUT 112 200

About Roivant Sciences Ltd.

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom.

  • Guggenheim
    Wed Nov 15, 14:05
    buy
    confirm
  • JP Morgan
    Tue Nov 14, 13:57
    buy
    confirm